debt_leverage_profile
Near debt-free balance sheet; minimal long-term debt (~$0-5M); 20bp rate rise has negligible P&L impact, under $100K annual interest cost increase
Inferred
Agent_Inference
interest_rate_sensitivity
Very low sensitivity; LeMaitre holds net cash position; rising rates modestly boost interest income rather than increase expense burden
Inferred
Agent_Inference
geopolitical_supply_exposure
Low intensity; China and India supply >60% of global API inputs, creating concentration risk.
Medium
GICS-commodity-overlay-v1
supply_chain_dependency
1) Single-source biomedical raw materials from EU/Asia suppliers; 2) Specialty PTFE and biological tissue sourcing concentrated in limited-geography vendors
Inferred
Agent_Inference
international_expansion_readiness
~55% revenue international; top markets Germany, France, Italy expose company to EUR/USD devaluation risk; 10% EUR decline ~$6-8M revenue headwind
Inferred
Agent_Inference
geographic_footprint
Operations in US, Germany, France, Italy, UK, Canada; EUR-denominated revenues ~40%+ of total; meaningful translation and transaction FX exposure
Inferred
Agent_Inference
commodity_exposure_profile
Low intensity; commodities: Active Pharmaceutical Ingredients, Rare Earth Elements, Natural Gas (energy), Plastics/Resins, Ethanol, Packaging Materials; geopolitical: China and India supply >60% of global API inputs, creating concentration risk.
Medium
GICS-commodity-overlay-v1
vendor_lock_dependency_score
No single vendor publicly disclosed at >30% input cost; biological/PTFE raw material suppliers are limited but diversified across 2-3 key sources
Inferred
Agent_Inference
business_model_type_primary
Medical device manufacturer and distributor; minimal cloud-native infrastructure; AWS/GCP termination would disrupt ERP/CRM but not core manufacturing
Inferred
Agent_Inference
business_model_type_secondary
Physical product manufacturer with direct sales force; cloud dependency is back-office level; 30-day termination manageable with migration to alternative providers
Inferred
Agent_Inference
switching_cost_profile
Low API coupling risk; LeMaitre uses standard ERP (SAP/Oracle class) systems; no proprietary API ecosystem; switching cost to alternative platforms is moderate
Inferred
Agent_Inference
howey_test_risk_index
Not applicable; revenue from medical device product sales; no investment contract, profit-sharing, or token structure; Howey Test risk is effectively zero
Inferred
Agent_Inference
regulatory_burden_tier
Very High
Medium
GICS-regulatory-overlay-v1
data_sovereignty_risk
Moderate GDPR exposure via EU patient/hospital data; CCPA exposure limited; company must maintain MDR compliance data protocols across EU member states
Inferred
Agent_Inference
antitrust_exposure_flag
Low antitrust risk; niche vascular surgery device market; market share in individual product categories (e.g., valvulotomes) may be high but market is small
Inferred
Agent_Inference
regulatory_exposure_profile
Very High burden; regimes: FDA, CMS, HHS, HIPAA, EMA, OIG; Drug pricing legislation and approval delays directly compress revenue visibility.
Medium
GICS-regulatory-overlay-v1
revenue_model_type
~100% transactional/product-sale revenue; no meaningful subscription or recurring contract revenue; reorder rates high but contractually transactional
Inferred
Agent_Inference
monetization_vector
Per-unit device sales to hospitals and vascular surgeons; direct sales force model; average selling prices $200-$2,000 per device depending on product line
Inferred
Agent_Inference
pricing_architecture
Niche monopoly pricing in several product lines (valvulotomes, carotid shunts); pricing power strong where LeMaitre is sole/dominant supplier; GPO pressure limits upside
Inferred
Agent_Inference
pricing_power_rating
High in proprietary legacy product lines with no competitive equivalent; moderate where generic or laparoscopic alternatives exist; overall pricing power rated 7/10
Inferred
Agent_Inference
target_gross_margin_bracket
71.5% Gross Margin (Premium (>60%))
High
SEC-XBRL
churn_vulnerability_index
No free-rider problem; physical consumable products require repurchase; surgeon habit and product familiarity create strong retention; low churn vulnerability
Inferred
Agent_Inference
headcount_cost_structure
Revenue growth is headcount-sublinear at moderate scale; direct sales force expansion needed for new geographies but manufacturing leverage improves at volume
Inferred
Agent_Inference
marginal_cost_of_growth
Marginal cost of growth moderate; incremental revenue requires some sales headcount and manufacturing capacity but gross margins ~60%+ support operating leverage
Inferred
Agent_Inference
franchise_compliance_risk
Not applicable; LeMaitre operates direct sales model, no franchise network
Inferred
Agent_Inference
customer_acquisition_metric
At 10x scale, hospital/surgeon TAM limits addressability; CAC via direct sales force ~$15-30K per account; LTV high given repeat purchasing over surgeon careers
Inferred
Agent_Inference
network_effect_present
No meaningful network effects; adoption driven by clinical outcomes and surgeon training; installed base creates switching costs but not compounding network dynamics
Inferred
Agent_Inference
asset_efficiency_ratio
12.2% Return on Assets (Excellent)
High
SEC-XBRL
recession_resistance_tier
Tier 2 recession resistant; vascular surgery is semi-elective but medically necessary; procedure volumes dip modestly in recessions but recover quickly
Inferred
Agent_Inference
customer_segment_primary
Vascular surgeons and hospital surgical departments; no single customer >5% revenue; top 10 customers likely <20% of revenue based on fragmented hospital market
Inferred
Agent_Inference
customer_segment_secondary
Secondary segment: hospital GPO-contracted procurement departments and international distributors in markets without direct sales presence
Inferred
Agent_Inference
characteristic_occupations
["11-0000 Management Occupations", "13-0000 Business and Financial Operations Occupations", "15-0000 Computer and Mathematical Occupations", "19-0000 Life, Physical, and Social Science Occupations", "21-0000 Community and Social Service Occupations", "23-0000 Legal Occupations", "29-0000 Healthcare Practitioners and Technical Occupations", "31-0000 Healthcare Support Occupations", "41-0000 Sales and Related Occupations", "43-0000 Office and Administrative Support Occupations", "51-0000 Production Occupations"]
High
SOC-2018/GICS-overlay
agent_automatable_labor_share
0.32 (HIL — ~32% of characteristic roles agent-automatable)
Medium
SOC-2018 + agentic-exposure-v1
capital_expenditure_profile
1.1% CapEx / Revenue (Low-CapEx Asset-Light)
High
SEC-XBRL
sec_cik
0001158895
High
SEC-EDGAR
ticker
LMAT
High
SEC-EDGAR